Aligos Therapeutics Inc. (ALGS)
NASDAQ: ALGS
· Real-Time Price · USD
7.70
0.12 (1.52%)
At close: Aug 15, 2025, 3:59 PM
7.70
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT
Aligos Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 965K | 311K | 629K | 1.27M | 1.06M | 986K | 2.68M | 3.24M | 6.89M | 2.72M | 3.54M | 4.11M | 3.69M | 2.57M | 367K | 1.54M | 1.54M | 910K |
Cost of Revenue | 259K | n/a | n/a | n/a | 610K | 674K | 775K | 681K | 769K | 844K | 897K | 906K | 889K | 983K | 28.6M | 28.13M | 24.55M | 22.87M |
Gross Profit | 706K | 311K | -42K | 1.27M | 451K | 312K | 1.91M | 2.56M | 6.12M | 1.88M | 2.64M | 3.2M | 2.8M | 1.59M | -28.23M | -26.59M | -23.01M | -21.96M |
Operating Income | -18.57M | -19.24M | -20.56M | -20.13M | -26.41M | -22.05M | -26M | -19.07M | -19.14M | -21.91M | -22.68M | -18.95M | -20.39M | -35.56M | -37.95M | -33.07M | -29.57M | -27.74M |
Interest Income | 396K | 842K | 314K | 457K | 319K | 580K | 1.59M | 1M | 955K | 748K | 845K | 466K | 212K | 86K | 176K | 20K | 72K | 105K |
Pretax Income | -15.68M | 43.13M | -82.12M | -19.17M | 5.25M | -34.84M | -27.92M | -18.01M | -18.03M | -22.92M | -21.84M | -18.66M | -19.88M | -35.56M | -37.77M | -33M | -29.79M | -27.63M |
Net Income | -15.86M | 43.09M | -82.15M | -19.26M | 5.06M | -34.86M | -27.89M | -18.04M | -18.79M | -22.95M | -21.89M | -18.62M | -19.92M | -35.62M | -37.71M | -33.12M | -29.82M | -27.67M |
Selling & General & Admin | 5.3M | 5.05M | 5.16M | 4.63M | 5.77M | 6.67M | 5.65M | 6.44M | 9.25M | 8.51M | 7.12M | 5.26M | 7.58M | 6.45M | 9.72M | 6.47M | 6.56M | 5.78M |
Research & Development | 13.98M | 14.5M | 16.03M | 16.77M | 21.1M | 16.37M | 22.26M | 15.87M | 16.78M | 18.14M | 19.1M | 17.79M | 16.51M | 31.68M | 28.6M | 28.13M | 24.55M | 22.87M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -13.37M | n/a | 54K | 152K | 254K | n/a | -182K | 304K | -91K | n/a | 50K | -298K | 6K |
Operating Expenses | 19.27M | 19.55M | 21.19M | 21.4M | 26.86M | 23.03M | 27.9M | 22.31M | 26.03M | 26.64M | 26.22M | 23.05M | 24.09M | 38.13M | 38.31M | 34.6M | 31.11M | 28.65M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 876K | n/a | n/a | n/a | 132K | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | -610K | n/a | -775K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 19.53M | 19.55M | 21.19M | 21.4M | 27.48M | 23.03M | 28.68M | 22.31M | 26.03M | 26.64M | 26.22M | 23.05M | 24.09M | 38.13M | 38.31M | 34.6M | 31.11M | 28.65M |
Income Tax Expense | 185K | 43K | 27K | 91K | 189K | -24K | -30K | 29K | 757K | 39K | 49K | -43K | 47K | 53K | -58K | 126K | 28K | 45K |
Shares Outstanding (Basic) | 10.35M | 8.41M | 6.28M | 6.27M | 6.26M | 156.15M | 24.87M | 43.5M | 43.22M | 42.91M | 42.84M | 42.76M | 42.67M | 42.51M | 42.34M | 42.4M | 37.62M | 37.43M |
Shares Outstanding (Diluted) | 10.35M | 8.71M | 6.28M | 6.27M | 6.27M | 156.15M | 24.87M | 43.5M | 43.22M | 42.91M | 42.84M | 42.76M | 42.67M | 42.51M | 42.34M | 42.4M | 37.62M | 37.43M |
EPS (Basic) | -1.53 | 5.12 | -13.08 | -3.07 | 0.81 | -5.58 | -1.12 | -0.41 | -0.43 | -0.53 | -0.51 | -0.44 | -0.47 | -0.84 | -0.89 | -0.78 | -0.79 | -0.74 |
EPS (Diluted) | -1.53 | -2.11 | -13.08 | -3.07 | 0.81 | -5.58 | -1.12 | -0.41 | -0.43 | -0.53 | -0.51 | -0.44 | -0.47 | -0.84 | -0.89 | -0.78 | -0.79 | -0.74 |
EBITDA | -15.42M | -18.73M | -19.89M | -19.46M | -26.41M | -21.37M | -27.15M | -18.39M | -18.37M | -23.07M | -22.16M | -17.76M | -19.5M | -34.58M | -37.95M | -32.03M | -28.86M | -26.76M |
EBIT | -15.68M | -19.24M | -20.56M | -20.13M | -26.41M | -22.05M | -26M | -19.07M | -19.14M | -23.92M | -22.68M | -18.95M | -20.39M | -35.56M | -37.95M | -33.07M | -29.57M | -27.74M |
Depreciation & Amortization | 259K | 510K | 671K | 667K | 610K | 674K | 775K | 681K | 769K | 844K | 897K | 906K | 889K | 983K | 1.01M | 967K | 925K | 873K |